PREVALENCE OF RENAL CALCULI AND ASSOCIATED RISK FACTORS IN PATIENTS WITH FLANK PAIN: A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
Renal stones, prevalence, ultrasound, PCNL, ESWL, ureteroscopy, surgical outcomes
Abstract
Background: Renal caliculi are a common cause of flank pain and impose a significant burden on healthcare systems worldwide. This study aimed to evaluate the prevalence of Renal Calculi in patients presenting with flank pain and assess the surgical outcomes of various stone removal procedures, with a focus on demographic and lifestyle-related risk factors.
Methods: This cross-sectional, hospital-based observational study included 250 patients with flank pain who underwent ultrasound imaging for the diagnosis of renal stones. Demographic data, lifestyle factors, and ultrasound findings were recorded. Of the patients diagnosed with Renal Calculi (n=90), surgical outcomes for extracorporeal shock wave lithotripsy (ESWL), ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL) were analyzed. Statistical analysis was performed using descriptive statistics.
Results: The prevalence of Renal Calculi in patients with flank pain was 36%, with the highest prevalence in the 46–60 year age group. Males had a higher prevalence (43.3%) than females (25%). Higher BMI, smoking, inadequate hydration, and high dietary salt intake were significantly associated with renal stone formation. PCNL had the highest success rate (100%) with no complications, while ESWL (87.5%) and URS (83.3%) had moderate success rates and mild to moderate complication rates.
Conclusion: Renal caliculi are highly prevalent in males, obese individuals, smokers, and those with high salt intake. PCNL is the most effective and safest surgical method for large renal stones. Public health efforts should focus on promoting hydration, dietary modifications, and weight management to prevent renal stones.
References
2. Lee YH, et al. Diet, lifestyle, and the risk of kidney stones. Nephrology Dialysis Transplantation. 2020;35(5):793-800.
3. Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 Nov;13(11):654-662. doi: 10.1038/nrurol.2016.154. Epub 2016 Aug 31.
4. Al-Shawi MM, Aljama NA, Aljedani R, Alsaleh MH, Atyia N, Alsedrah A, Albardi M. The Role of Radiological Imaging in the Diagnosis and Treatment of Urolithiasis: A Narrative Review. Cureus. 2022 Dec 28;14(12):e33041. doi: 0.7759/cureus.33041..
5. Patel ND, et al. The impact of gender and age on kidney stone disease: An epidemiological study. Kidney International. 2022;101(2):364-371.
6. Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of Kidney Stones: Influence of Dietary Factors, Dietary Patterns, and Vegetarian-Vegan Diets. Nutrients. 2020 Mar 15;12(3):779. doi: 10.3390/nu12030779.
7. ang J, Narendrula A, El-Zawahry A, Sindhwani P, Ekwenna O. Global Trends in Incidence and Burden of Urolithiasis from 1990 to 2019: An Analysis of Global Burden of Disease Study Data. Eur Urol Open Sci. 2022 Jan 3;35:37-46. doi: 10.1016/j.euros.2021.10.008.
8. Stevenson JG, et al. Diagnostic accuracy of ultrasound in renal colic: Hospital-based statistics. Emergency Medicine Journal. 2021;38(7):517-523.
9. Scales CD, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-5.
10. Turney BW, et al. The increasing prevalence of kidney stones in the United Kingdom and its association with gender, age and obesity. BJU Int. 2012;109(7):1093-6.
11. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48(6):905-15.
12. El-Zoghby ZM, et al. Kidney stones and smoking: An epidemiological study. Urology. 2011;77(5):1024-7.
13. Curhan GC, et al. Fluid intake and the risk of kidney stones formation. N Engl J Med. 1996;335(26):1549-56.
14. Heaney RP. Effects of salt intake on calcium metabolism. Ann Intern Med. 1998;128(5):337-42.
15. Türk C, et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016;69(3):475-82.
16. Assimos D, et al. Surgical management of stones: American Urological Association/Endourological Society guideline, part II. J Urol. 2016;196(4):1161-9.